Washington: Swiss Drugmaker Roche Has Won U.S. Antitrust Approval For Its $4.3 Billion Deal To Buy Gene Therapy Specialist Spark Therapeutics, The Federal Trade Commission Said On Monday, Clearing The Way For The Swiss Drugmaker'S Push Into Treating Rare Diseases Including Hemophilia A.The Ftc Approved The Deal, Which Was Originally Announced In February, Without Requiring Any Asset Sales To Ensure That The Planned Merger Complies With Antitrust Law, The Agency Said In A Statement.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!